In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Leap Therapeutics Inc (NASDAQ: LPTX) closed the day trading at $0.34 down -12.39% from the previous closing price of $0.38. In other words, the price has decreased by -$12.39 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
For a better understanding of LPTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on January 29, 2025, Downgraded its rating to Neutral and sets its target price to $1.25 from $9 previously.
On June 28, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $8.Rodman & Renshaw initiated its Buy rating on June 28, 2024, with a $8 target price.
Stock Price History:
Over the past 52 weeks, LPTX has reached a high of $4.79, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -12.78%, while the 200-Day Moving Average is calculated to be -83.06%.
Shares Statistics:
A total of 38.33M shares are outstanding, with a floating share count of 30.74M. Insiders hold about 25.81% of the company’s shares, while institutions hold 27.89% stake in the company.
